Showing results (241-250 of 301) with videos related to

Sort By:
Pageof 31
JAMA|April 25, 1980
A case-control study of menopausal estrogen therapy and breast cancerR K Ross, A Paganini-Hill, V R Gerkins, et al.
Medical and Pediatric Oncology|January 1, 1975
The influence of chemotherapy on the prognosis of rhabdomyosarcomaJ A Ortega, G E Rivard, H Isaacs, et al.
American Journal of Epidemiology|August 1, 1995
Cost-efficient design of a diet validation studyD O Stram, M P Longnecker, L Shames, et al.
Gynecologic Oncology|January 6, 2000
Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormoneW Zheng, J J Lu, F Luo, et al.
British Journal of Cancer|November 1, 1987
Sex hormone binding globulin and risk factors for breast cancer in a population of normal women who had never used exogenous sex hormonesJ W Moore, T J Key, R D Bulbrook, et al.
The Journal of Steroid Biochemistry and Molecular Biology|October 1, 1991
Cigarette smoking and steroid hormones in womenT J Key, M C Pike, J A Baron, et al.
Contraception|February 1, 1989
The relationships of SHBG with current and previous use of oral contraceptives and oestrogen replacement therapyT J Key, M C Pike, J W Moore, et al.
The Prostate|September 19, 1997
Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer riskS A Devgan, B E Henderson, M C Yu, et al.
Epidemiology and Infection|December 14, 2011
Evidence of genetic susceptibility to infectious mononucleosis: a twin studyA E Hwang, A S Hamilton, M G Cockburn, et al.
British Journal of Cancer|June 21, 2007
Active and passive smoking and the risk of breast cancer in women aged 36-45 years: a population based case-control study in the UKA W Roddam, K Pirie, M C Pike, et al.
Pageof 31